| Page 2035 | Kisaco Research
 

Guy Smith

Vice President
National Farmers Union

Guy Smith

Vice President
National Farmers Union

Guy Smith

Vice President
National Farmers Union
 

Dr. William Abraham

Director, New Product and Process Technology
Monsanto

Dr. William Abraham

Director, New Product and Process Technology
Monsanto

Dr. William Abraham

Director, New Product and Process Technology
Monsanto
 

Dr. Roy Chen

Formulation Team Lead
Adama

Dr. Roy Chen

Formulation Team Lead
Adama

Dr. Roy Chen

Formulation Team Lead
Adama
 

Dr. Jaap van Wenum

Chairman of Arable Farming
LTO Nederland

Dr. Jaap van Wenum

Chairman of Arable Farming
LTO Nederland

Dr. Jaap van Wenum

Chairman of Arable Farming
LTO Nederland
 

Dr. Andrew Hewitt

Department of Agriculture and Food Sciences
University of Queensland

Dr. Andrew Hewitt

Department of Agriculture and Food Sciences
University of Queensland

Dr. Andrew Hewitt

Department of Agriculture and Food Sciences
University of Queensland
 

Dr. Melanie Kah

University of Vienna

Dr. Melanie Kah

University of Vienna

Dr. Melanie Kah

University of Vienna
 

Dr. Jim Bullock

Co-founder and Director
iFormulate

Dr. Jim Bullock

Co-founder and Director
iFormulate

Dr. Jim Bullock

Co-founder and Director
iFormulate
 

Dr. David Calvert

Co-Founder and Director
iFormulate

Dr. David Calvert

Co-Founder and Director
iFormulate

Dr. David Calvert

Co-Founder and Director
iFormulate
 

Mr. Jishu Shi

Professor, Kansas State University, Director
US China Center for Animal Health

Mr. Jishu Shi

Professor, Kansas State University, Director
US China Center for Animal Health

Mr. Jishu Shi

Professor, Kansas State University, Director
US China Center for Animal Health
 

Linda Rhodes

VMD, PhD, Independent and ex-CSO
Independent Animal Health

Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

Linda Rhodes

VMD, PhD, Independent and ex-CSO
Independent Animal Health

Linda Rhodes

VMD, PhD, Independent and ex-CSO
Independent Animal Health

Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.